GFAP and frontotemporal dementia: We found that the FTD DEGs, AKT3, UBE2N, VDAC1, ADCYAP1R1, C4A, and GFAP showed significant comorbidity in breast invasive carcinoma patients at a p-value < 0.05 (Figure 2).